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Abstract In postnatal organisms, insulin is well known as
an essential anabolic hormone responsible for maintaining
glucose homeostasis. Its biosynthesis by the pancreatic
beta cell has been considered a model of tissue-specific
gene expression. However, proinsulin mRNA and protein
have been found in embryonic stages before the formation
of the pancreatic primordium, and later, in extrapancreatic
tissues including the nervous system. Phylogenetic studies
have also confirmed that production of insulin-like
peptides antecedes the morphogenesis of a pancreas, and
that these peptides contribute to normal development. In
recent years, other roles for insulin distinct from its
metabolic function have emerged also in vertebrates.
During embryonic development, insulin acts as a survival
factor and is involved in early morphogenesis. These
findings are consistent with the observation that, at these
stages, the proinsulin gene product remains as the precursor
form, proinsulin. Independent of its low metabolic activity,
proinsulin stimulates proliferation in developing neuro-
retina, as well as cell survival and cardiogenesis in early
embryos. Insulin/proinsulin levels are finely regulated
during development, since an excess of the protein
interferes with correct morphogenesis and is deleterious
for the embryo. This fine-tuned regulation is achieved by
the expression of alternative embryonic proinsulin tran-
scripts that have diminished translational activity.
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We who study developmental biology are the
inheritors of embryology’s concepts, organisms and
sense of wonder. From other sources, we have
received a new set of tools with resolving power far
greater than what was available a generation ago.
Scott F. Gilbert, 1991
A Conceptual History of Modern Embryology
As time goes by
Twenty-five years ago, one of us, then a young
postdoctoral fellow, arrived at the National Institutes of
Health in Bethesda (MD, USA), thinking that she would
work on the dysfunction of receptors in insulin-resistant
patients. Having trained as a clinical endocrinologist, the
first conversation with the Diabetes Branch chief, Jesse
Roth, her tutor for the next 2 years, was a shock. Roth, who
was an Evo-Devo [1] pioneer without knowing it himself,
told the naïve fellow that insulin might have arisen millions
of years ago in evolution and, therefore, be present in
primitive organisms lacking even a pancreas. Indeed,
together with Derek LeRoith, who is now chief of the
Division of Endocrinology and Diabetes at The Mount
Sinai School of Medicine, he, Roth, had found molecules
similar to mammalian insulin in the heads of flies and in
nematodes [2]. The astonished young postdoctoral fellow
could not maintain a defensive sceptical attitude for very
long.
Insulin, it seemed, could be more than a hormone,
maybe a conserved signalling gene product, and its cellular
functions represent essential mechanisms in evolution and
development. A big role for a small-sized protein! The
enthusiasm over this broad view of insulin’s role in
phylogeny was not universal. It was easier to see how right,
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and clearly ahead of their time, were some of Roth’s and
colleagues views on hormones and receptors [3], after the
completed sequences of the genomes of Drosophila
melanogaster [4] and Caenorhabditis elegans [5] con-
firmed that the production of insulin-like peptides precedes
in evolution the morphogenesis of a pancreas, and that
these peptides contribute to normal development.
As another former fellow of the Diabetes Branch at NIH
recently wrote, in a thorough historical perspective of more
than three decades of research into the structural biology of
insulin-receptor interaction, ‘insulin proved to be a
bonanza for protein chemists and…may arguably deserve
the title of protein of the 20th century’ [6]. Insulin, we
agree, does deserve a special place among molecules that
have opened new biochemical and biological avenues for
understanding life. When insulin was the first protein to
have its primary amino acid sequence resolved, by Fred
Sanger in 1953 [7], it could not be anticipated that besides
saving the lives of millions of insulin-dependent diabetic
patients, it would be a universal survival protein for cells in
culture [8], and also become a paradigm for studies on gene
expression, protein processing and regulated protein
secretion.
Postnatally in vertebrates, insulin is an essential anabolic
hormone responsible for maintaining glucose homeostasis.
Its biosynthesis by pancreatic beta cells is a model of
tissue-specific gene expression. The mature beta cells are
the ‘insulin factory’ of the organism [9, 10], where high
levels of proinsulin are transcribed and translated. The
primary protein product, proinsulin, matures to insulin
through processing executed by the endopeptidases protein
convertase (PC)2 and PC3, and is accumulated in the
secretory granules, which respond to regulated secretion
signals. Circulating insulin levels are largely dependent on
food intake, and glucose, among other metabolites, is the
central regulator of pancreatic insulin biosynthesis at
multiple steps [11]. The important action of insulin as a
pancreatic hormone might have diverted recognition of
other relevant roles played by insulin, either earlier in life,
during development, or locally in tissues such as the
nervous system. Here, we present an update of what
insulin, its precursor proinsulin and insulin receptors
have taught us about their developmental nonmetabolic
functions.
Insulin across animal kingdoms
The insulin-related peptide family represents a group of
structurally similar molecules with a characteristic hydro-
phobic core and six cysteine residues. In the human
genome, the insulin-related gene family comprises ten
members: in addition to the best characterised proinsulin
and IGF1 and −2, seven peptides related to relaxin have
been found [12]. Focusing our attention on the closest
relatives to insulin, strong evidence suggests that proinsu-
lin, IGF1 and IGF2 have evolved by gene duplication from
a common ancestor gene [13]. These three proteins present
high amino acid-sequence identity [14, 15], homologue
tyrosine kinase receptors [16, 17] and overlapping intra-
cellular signalling pathways [18, 19]. These peptides affect
multiple and diverse biological functions including metab-
olism, cell size, cell proliferation, differentiation, survival
and growth, both during development and in adult
organisms [20–23].
Recently, molecular genetics techniques have allowed
the phylogenetic origin of the proinsulin gene to be
determined (reviewed in [13]). Insulin-like peptides and
insulin receptor-like complementary DNAs have been
identified in organisms that diverted from vertebrates a
long time ago, including insects, molluscs and nematodes.
The insulin family of proteins can be traced to the early
multicellular eukaryotes [24], whereas no insulin-like
genes have been found in the yeast genome [25]. There-
fore, this gene family appears to have co-evolved with the
appearance of the metazoan branch. Amphioxus, the
postulated ancestor from which vertebrates evolved, has a
single insulin-like peptide gene that is equally similar to
insulin and IGFs [26]. Accordingly, the insulin receptor-
like protein in amphioxus presents comparable amino acid
homology to the human insulin and IGF1 receptors, and it
is equally activated by human insulin and IGF1 [27]. Thus,
the amphioxus insulin-like peptide and its receptor may be
the ancestral genes from which vertebrate insulin, IGFs,
and their corresponding receptor genes were derived. The
high conservation between IGF1 and IGF2 amino acid
sequences suggests that they originated as a result of a
more recent gene duplication event during vertebrate
phylogeny [28].
Frequently, several insulin-like peptide genes are found
in invertebrates, although only one insulin-like receptor
protein may emerge. The expression of some of those
molecules is not restricted to the gut tissue, but it is also
detected in neural cells. Thus, insulin-like peptides are
considered neuroendocrine modulators associated with
development and cell growth. In addition, insulin-like
peptide signalling is also involved in reproductive function
and longevity. Mutations of the insulin-like receptor in D.
melanogaster and C. elegans increase the life span of the
organism, an observation that has been reproduced in
mouse IGF1 receptor heterozygotic null mutations
[29–31]. Chan and Steiner [13] proposed that the ancestral
insulin-like gene product function served primarily as a
mitogenic growth factor but, after gene duplication, the
mitogenic activity was retained by the vertebrate IGFs.
This allowed the insulin gene product to develop a new
function, the regulation of metabolism, and IGFs to
become the main drivers of fetal and postnatal growth
[32]. Some experimental data support the notion that this
diversification and functional relay found in evolution is
also present in development (review, see [33]).
Insulin throughout an organism’s life
In recent years, alternative functions to insulin’s role as a
pancreatic hormone have been elucidated (reviewed in [23,
34, 35]). In parallel to these novel functions, investigators
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have begun to describe new mechanisms of the regulation
of proinsulin gene expression. These actions and regulatory
mechanisms appear to be reminiscent of those found in
invertebrates. In this part of the review, we will focus on
proinsulin/insulin expression and function in early embry-
onic stages of vertebrates (Table 1).
Prepancreatic and extrapancreatic proinsulin
expression in early development
In several vertebrate species, proinsulin mRNA is first
detected before the formation of the pancreatic primordium
[36–39], and later in development, in extrapancreatic
tissues [40–45]. Although prepancreatic and extrapancre-
atic proinsulin gene expression is much lower than in the
pancreas [36], proinsulin mRNA can be unequivocally
detected in the chick embryo as early as 0.5 day of
embryonic development (Fig. 1a), corresponding to gas-
trulation [46], as well as in the retinal neuroepithelium at
embryonic day 3 [47]. Proinsulin protein is detected in
discrete cells located in the three embryonic layers but,
mainly, in the neuroepithelium [46, 48] (Fig. 1b). Re-
markably, a broad presence of proinsulin mRNA and
protein is observed prior to IGF1 expression (Fig. 1) [46,
48]. Conversely, both insulin and IGF1 receptor mRNA are
expressed at early developmental stages [49] (Fig. 2) and
the corresponding tyrosine-kinase activity can be measured
upon ligand binding [50]. Proinsulin mRNA expression
also precedes IGF1 mRNA expression in the embryonic
chick retina, while the transcripts for both receptors are
expressed simultaneously [43, 51] (Fig. 2b).
Concerning its translation product, proinsulin remains
unprocessed in the neurulating embryo and the neuroretina,
due to lack of expression of at least one of the prohormone
convertases, namely PC2 [44, 48]. The livers of mid- and
late-stage chick embryos also lack PC2 expression, and
preferentially yield proinsulin [44]. Muglia and Locker
[40] found similar amounts of proinsulin and insulin
produced by the yolk sac of late gestational rats. Since
young embryos usually lack typical endocrine granules
[52], prepancreatic and extrapancreatic proinsulin is likely
to be secreted by a constitutive secretory pathway. In
cultured neuroretina, rapid proinsulin secretion to the
medium and accumulation occur in a few hours, even in the
absence of secretagogues [53].
Receptors mediating proinsulin/insulin signals in early
embryos
Membrane-bound receptor and signalling pathways med-
iating proinsulin action in early development are less well
studied than those of insulin. Binding studies in the chick
neuroretina, whose size allows biochemical approaches
with primary tissue, revealed an unexpected scenario.
Proinsulin may act through heterodimeric or ‘hybrid’
insulin/IGF1 receptors formed by one α/β monomer of the
insulin receptor and another α/β monomer of the IGF1
receptor. In the neuroretina, heterodimeric receptors are
found at early stages, when the homodimeric insulin
receptor is apparently absent. The proportion of hybrid
receptors demonstrated by crosslinking decreases as retinal
development proceeds, and homodimeric insulin receptors
become demonstrable by immunoprecipitation [54]. Inter-
estingly, classical binding-displacement studies revealed
this atypical class of receptor that not only binds insulin
and IGF1 with equivalent high affinity, but also recognises
proinsulin with medium to high affinity (EC50 of 10
−8 mol/l)
[54] (Fig. 2c). Hybrid insulin/IGF1 receptors have also
been described in postnatal tissues of other species [55, 56].
However, the binding characteristics of the known
mammalian hybrid receptors differ from those found in
the proliferative neuroretina, since they have higher affinity
for IGF1 than for insulin. Pandini et al. [57] suggest that the
insulin receptor splicing isoform may confer differences in
ligand affinity of the hybrid receptor. This heterogeneity of
the insulin receptor family, which provides possible
alternative signalling mechanisms, fits nicely with the
expanding physiological roles of insulin/proinsulin.
Preliminary studies have shown that Akt, a signalling
molecule activated downstream of canonical insulin
receptors in metabolic target tissues, is also implicated in
the survival action of insulin during development. Akt
phosphorylation is increased in proliferative neuroretina
[51] and neurulating embryos (unpublished data of the
authors) after addition of insulin. The specific proinsulin
signalling pathway triggered by proinsulin during devel-
opment deserves further study.
Developmental mechanisms of the regulation
of proinsulin gene expression
The regulation of proinsulin gene expression in early
embryogenesis also differs from its pancreatic regulation.
In postnatal organisms, the plasma glucose concentration
controls insulin expression at multiple levels. Glucose
stimulates proinsulin gene transcription [58], as well as
insulin mRNA processing and stability [59]. Initiation and
elongation rates of insulin protein synthesis in the pancreas
are also stimulated by glucose [60–62]. In contrast,
embryonic proinsulin mRNA levels are not glucose-
dependent but developmentally regulated [63], an observa-
tion that indicates alternative mechanisms of regulation.
Indeed, the use of alternative transcription start sites in
embryonic extrapancreatic tissues has been reported [40,
Table 1 Proinsulin and insulin in life stages
Embryo Postnatal
Function Survival Metabolic
Active form Proinsulin Insulin






41, 48]. We have found two alternative, embryonic-specific
transcripts (Pro1B and Pro1B1) in the neurulating chick
embryo, also present in the mouse embryo (Fig. 3). An
alternative transcription start site generates an embryonic
proinsulin mRNA (Pro1B) with an extended 5′ untrans-
lated region (UTR), which nonetheless shares the coding
region with pancreatic mRNA (Pro1A) [48]. Translation
from this embryonic transcript is efficiently repressed by
two methionine codons (AUGs) upstream (upAUG) to the
proinsulin AUG [64] (Fig. 3). The constrained translation
imposed by upAUGs has been found in other proteins with
critical functions [65–67]. In the case of embryonic
proinsulin, moderate proinsulin excess induces embryonic
malformations (Fig. 4b–e) [64], and larger amounts of
proinsulin and insulin are teratogenic in embryos in early
organogenesis [68], supporting a physiological function for
translational repression. The other alternative transcript
(Pro1B1) is generated by retention of the first intron in the
5′ UTR, resulting in a large and structured 5′ UTR that
nearly blocks proinsulin translation (Fig. 3) [69]. The use
of multiple and developmental-specific promoters or
transcription start sites has been extensively described for
both IGF1 and IGF2 [70]. They provide alternative
mechanisms for developmental stage- or tissue-specific
expression of genes with critical proliferation or survival
functions.
Biological functions of proinsulin/insulin in early
development
In the last 20 years, an increasing number of observations
has been published supporting the physiological role of
insulin signalling in embryonic development. Both block-
ing anti-insulin antibodies and an excess of insulin are
deleterious for growth in the chick embryo [68, 71]. In
cultured rat embryos, low insulin levels cause retarded
growth and development [72]. More recent studies showed
that downregulation of proinsulin mRNA or insulin
receptor mRNA by antisense oligodeoxynucleotides results
in an increase in cell death and developmental delay in the
neurulating chick embryo (Fig. 4f–h) [46, 48], whereas in
ovo treatment with blocking anti-insulin or anti-insulin
receptor antibodies increases cell death and decreases
neuronal numbers in the embryonic chick retina (Fig. 5)
[51]. In parallel to this major role in survival/death control,
insulin and proinsulin may also play a role in early
morphogenesis and cardiogenesis [69, 73, 74]. Moreover,
human fetuses lacking insulin receptor are significantly
growth-retarded, showing a stronger phenotype than the
insulin receptor knockout mouse (reviewed in [75]).
Differences in developmental and organ maturation
patterns may account for this discrepancy.
3Fig. 1 Proinsulin and IGF1 expression in early chick embryo
development. a In situ hybridisation of proinsulin (Proins) and IGF1
in chick embryos at different embryonic days of development (E).
E0.5 corresponds to gastrulation, E1.5 to neurulation and E2.5 to
early organogenesis. Arrows indicate the pancreatic buds. The
pseudocolour scale reflects the highest signal in red and the lowest
in blue. Reprinted with permission from [46] (copyright 1997, The
Endocrine Society). b Immunostaining of Proins and IGF1, with
mid-level transversal cryosections of E1 embryos and transversal
cryosections of E2.5 embryos caudal to vitelline arteries. The insert
shows a higher magnification detail of the E1 section and
arrowheads indicate neuroepithelial cells. Note that proinsulin
mRNA and protein are detected prior to the pancreatic bud
formation and antecede IGF1 expression. DE, digestive endoderm;
DM, dermamyotome; EC, ectoderm; EN, endoderm; FP, floor plate;
N, notochord; NM nephrogenic mesenchyme; NT, neural tube; RT
nephric tube. Reprinted with permission from [48] (copyright 2002,
The American Diabetes Association)
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It is worth noting that proinsulin, being a metabolically
low-activity insulin precursor [76], stimulates both growth
of proliferating neuroretina in culture, with a potency only
slightly lower than that of insulin or IGF1 [53], and
cardiogenesis in the early embryo [69]. Proinsulin is also
nearly as effective as insulin in preventing cell death in
cultured neurulating embryos under growth factor depri-
vation conditions [48]. In a pharmacologically opposite
approach, an excess of proinsulin is harmful to the embryo
and interferes with correct morphogenesis, probably due to
an excessive reduction in cell death (Fig. 4b–e) [64]. These
unexpected biological roles of proinsulin fit very nicely
with the observations on lack of proinsulin protein
processing in retina and early embryo [44, 48].
Relevance and challenges ahead
The studies reviewed here define a broader and new
scenario for the biological roles of proinsulin/insulin
(Table 1). Proinsulin mRNA is present in the early embryo
before the pancreas differentiates and in extrapancreatic
tissues, in particular the neural tissue. The translation
product, unprocessed proinsulin, appears to bind a
promiscuous hybrid receptor, activating cell survival
mechanisms during critical neurulation and neurogenesis
processes, and inducing expression of cardiac genes; this
has a strong impact on cell survival and embryo develop-
ment. Precise, embryonic-specific regulation of the proin-
sulin gene and protein leads to the right amount to maintain
adequate levels of cell death. We view proinsulin’s
embryonic action as the first wave of the multiple
overlapping roles that the precursor and, later, mature
insulin have in the life cycle of an organism (Fig. 6).
The clinical relevance of pancreatic insulin dysfunction
is undisputed. The studies on prepancreatic and extra-
3Fig. 2 Insulin and IGF1 receptors expression in the developing
chick embryo and retina. a RT-PCR followed by Southern blot
analysis of RNA from the indicated embryonic day of development
(E) of chick embryos. IR, insulin receptor; IGF1R, IGF1 receptor.
RNase treatment confirmed the absence of genomic DNA contam-
ination. Reprinted with permission from [49]. b E6 embryo
photography (above), and in situ hybridisation of IR and IGF1R
in horizontal E6 embryo head sections, approximately at the level
indicated in photography. RET, retina; TEC, optic tectum. Reprinted
with permission from [43] (copyright 1994, Eur J Neurosci).
Binding–competition curves for IGF1 (c) and insulin (Ins) (d).
Crude membranes of E6 neuroretina were incubated with 125I-IGF1
or 125I-insulin tracer in the absence or presence of unlabelled human
proinsulin (open circles), chicken insulin (open squares) or chicken
IGF1 (open triangles) as competitors. M, mol/l. Reprinted with
permission from [54] (copyright 1999, The Endocrine Society)
Fig. 3 Scheme of proinsulin transcripts. The pancreatic (Pro1A)
and embryonic (Pro1B and Pro1B1) chick proinsulin mRNAs:
exons (E), introns (I). The common exons 2 and 3 are in grey and the
variable exon 1 (5′ UTR) is in blue. The proinsulin translation
initiation codon (ATG), as well as the two upstream ATGs (atg) are
indicated
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pancreatic insulin expression and function in humans may
unravel relevant clinical implications. For example, it is
important to characterise the proinsulin mRNA final
protein product in non-pancreatic tissues, particularly
when trying to generate insulin-secreting pancreatic beta-
like cells derived from stem cells, a complex and debated
strategy [77–81]. Further, high glucose levels induce
apoptotic cell death in the mouse pre-implantation embryo
[82, 83] and during neurulation [84]. Deregulated cell
death occurs in the genesis of diabetic embryopathy [82–
86], an observation that is consistent with the essential role
of programmed cell death in embryonic development [87–
89]. It is nonetheless likely that congenital malformations
are the result of diverse types of aberrant signals [90, 91]
and not only the consequence of maternal hyperglycaemia.
Indeed, congenital defects are still more frequent in infants
of diabetic mothers than in the general population, in spite
of adequate hyperglycaemia control in a large proportion of
diabetic pregnant women. Recent reports have observed
Fig. 4 Proinsulin/insulin effect on cell death in early chick embryo.
a Embryo diagram, with inset of regions magnified (b–e). Devel-
opmental abnormalities (b–e) observed in E1.5 neurulating chick
embryos after 8 h treatment in ovo with 50 μl 10−7 mol/l human
proinsulin. Frequent abnormalities included neural tube defects such
as asymmetric anterior neuropore closure, collapsed optic vesicles
(b, c), and flexures in the neural tube. These effects are consistent
with a clear reduction in naturally occurring cell death as
demonstrated by TUNEL staining (bright dots) in regions in
which malformations are observed (e), compared with control
embryos (d). np, anterior neuropore; ov optic vesicles. Reprinted
with permission from EMBO J [64] (copyright 2003, Macmillan
Publishers). f–h In ovo treatment with insulin receptor antisense
oligodeoxynucleotides (AS IR) for 10 h increased the proportion of
apoptotic cells compared to control embryos incubated with random
oligodeoxynucleotides (IR RAN) or untreated embryos (in vivo).
Reprinted with permission from [48] (copyright 2002, The Amer-
ican Diabetes Association)
Fig. 5 Insulin function in the developing neuroretina. a E4 chick
embryo; b dissected E4 neuroretina with the lens still in place; c
isothanas representing density of TUNEL-stained cells per square
mm of E4 chick neuroretinas previously treated in ovo with anti-
proinsulin/insulin Igs (Anti-Ins), anti-insulin receptor Igs (Anti-IR)
antibodies or the corresponding control Igs (Control) for 2 days.
Orientation of the retinas is indicated: D, dorsal; V, ventral; N, nasal;
T, temporal. Reprinted with permission from [51]
Fig. 6 Schematic overview of the proposed main influence of
proinsulin and insulin as development proceeds. The idealised
waves correspond to major processes or types of roles. The cell
survival effect may underlay and facilitate others, and may be
important in certain type of cells until advanced life
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that the correlation between congenital malformations in
infants of diabetic mothers and pre-pregnancy BMI is
higher than that between congenital malformations and
maternal blood glucose values [92], and that oxidative
stress makes an important contribution to the increase in
neural tube defects [93]. In addition, obesity and
hyperinsulinaemia have been suggested as risk factors for
neural tube defects in the general population [94]. We
anticipate that changes in proinsulin expression in placenta
and fetal tissues may be among the risk factors during
pregnancy in diabetic and obese women. Difficult as it may
be to approach direct analysis in humans, it is necessary to
continue unravelling the unexpected, physiological role of
proinsulin in development with a naïve sense of wonder.
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